First Time Loading...

Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 3.005 USD -0.17% Market Closed
Updated: May 8, 2024

Mereo Biopharma Group PLC
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mereo Biopharma Group PLC
Pre-Tax Income Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Mereo Biopharma Group PLC
NASDAQ:MREO
Pre-Tax Income
-£36.1m
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Pre-Tax Income
-$176.1m
CAGR 3-Years
-155%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Pre-Tax Income
-$208.4m
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Pre-Tax Income
-$166.4m
CAGR 3-Years
-43%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Pre-Tax Income
-£60.9m
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Pre-Tax Income
£38.7m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
2%

See Also

What is Mereo Biopharma Group PLC's Pre-Tax Income?
Pre-Tax Income
-36.1m GBP

Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Pre-Tax Income amounts to -36.1m GBP.

What is Mereo Biopharma Group PLC's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 3Y
4%

The average annual Pre-Tax Income growth rates for Mereo Biopharma Group PLC have been 4% over the past three years .